ProQR Therapeutics BV (PRQR) — Cash Flow Reinvestment Rate
ProQR Therapeutics BV (PRQR) has a Cash Flow Reinvestment Rate of 0.01x as of March 2023, reinvesting $225.00K (capex $136.00K plus investments $-89.00K) from operating cash flow of $44.73 Million. Check ProQR Therapeutics BV cash earnings quality to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
ProQR Therapeutics BV Cash Flow Reinvestment Rate (2023–2023)
Historical reinvestment intensity for ProQR Therapeutics BV across 1 annual periods. Explore how much of ProQR Therapeutics BV's assets are long-term investments to see how much of total assets are deployed in long-term investments.
Annual Cash Flow Reinvestment Rate for ProQR Therapeutics BV (2023–2023)
Year-by-year capital reinvestment analysis for ProQR Therapeutics BV. For live market cap and broader valuation context, see ProQR Therapeutics BV market capitalisation.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2023 | 0.26x | $5.65 Million | $21.55 Million | $1.37 Million | — |